No Data
Azenta Gets US Approval for Long-read WGS Test
Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology
Volta Labs Joins PacBio Compatible Program to Help PacBio Customers Scale Sequencing Through Automated Library Prep
PacBio Shares Are Trading Higher After the Company Announced SPRQ Sequencing Chemistry for Its Revio Sequencing Systems.
PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to Less Than $500
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Is a Favorite Amongst Institutional Investors Who Own 86%